Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer

We utilized three tiers of screening to identify novel therapeutic agents for pancreatic cancers. First, we analyzed 14 pancreatic cancer cell lines against a panel of 66 small‐molecule kinase inhibitors and dasatinib was the most potent. Second, we performed RNA expression analysis on 3 dasatinib‐r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Chien, Wenwen, Sun, Qiao-Yang, Lee, Kian Leong, Ding, Ling-Wen, Wuensche, Peer, Torres-Fernandez, Lucia A., Tan, Siew Zhuan, Tokatly, Itay, Zaiden, Norazean, Poellinger, Lorenz, Mori, Seiichi, Yang, Henry, Tyner, Jeffrey W., Koeffler, H. Phillip
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4387089/
https://ncbi.nlm.nih.gov/pubmed/25637283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.01.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados